
Acasti Pharma ACST
Quartalsbericht 2025-Q4
hinzugefügt 12.02.2026
Acasti Pharma DPO 2011-2026 | ACST
DPO Jährlich Acasti Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 4.39 K | - | - | - | - | 1.68 K | 383 | 400 | 292 | 39.5 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 39.5 K | 292 | 7.77 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
5.06 K | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.63 | -4.4 % | $ 191 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 0.73 | -0.03 % | $ 33.4 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.12 | - | $ 649 M | ||
|
Exelixis
EXEL
|
148 | $ 51.1 | -0.37 % | $ 13.9 B | ||
|
Karyopharm Therapeutics
KPTI
|
149 | $ 8.9 | 0.56 % | $ 1.08 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 17.3 | -5.57 % | $ 809 M | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 3.03 | 6.32 % | $ 283 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Gilead Sciences
GILD
|
45.3 | $ 132.06 | -0.74 % | $ 164 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.3 | 3.14 % | $ 64.2 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 21.57 | -0.55 % | $ 2.74 B | ||
|
Fennec Pharmaceuticals
FENC
|
894 | $ 9.24 | 36.48 % | $ 264 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K |